Literature DB >> 10766741

Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

D Rudolph1, W C Yeh, A Wakeham, B Rudolph, D Nallainathan, J Potter, A J Elia, T W Mak.   

Abstract

Phosphorylation of IkappaB, an inhibitor of NF-kappaB, is an important step in the activation of the transcription factor NF-kappaB. Phosphorylation is mediated by the IkappaB kinase (IKK) complex, known to contain two catalytic subunits: IKKalpha and IKKbeta. A novel, noncatalytic component of this kinase complex called NEMO (NF-kappaB essential modulator)/IKKgamma was identified recently. We have generated NEMO/IKKgamma-deficient mice by gene targeting. Mutant embryos die at E12.5-E13.0 from severe liver damage due to apoptosis. NEMO/IKKgamma-deficient primary murine embryonic fibroblasts (MEFs) lack detectable NF-kappaB DNA-binding activity in response to TNFalpha, IL-1, LPS, and Poly(IC) and do not show stimulus-dependent IkappaB kinase activity, which correlates with a lack of phosphorylation and degradation of IkappaBalpha. Consistent with these data, mutant MEFs show increased sensitivity to TNFalpha-induced apoptosis. Our data provide in vivo evidence that NEMO/IKKgamma is the first essential, noncatalytic component of the IKK complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766741      PMCID: PMC316493     

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  27 in total

1.  Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice.

Authors:  M Tanaka; M E Fuentes; K Yamaguchi; M H Durnin; S A Dalrymple; K L Hardy; D V Goeddel
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

2.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation.

Authors:  J DiDonato; F Mercurio; C Rosette; J Wu-Li; H Suyang; S Ghosh; M Karin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 3.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

Authors:  I M Verma; J K Stevenson; E M Schwarz; D Van Antwerp; S Miyamoto
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

4.  IKK1-deficient mice exhibit abnormal development of skin and skeleton.

Authors:  Q Li; Q Lu; J Y Hwang; D Büscher; K F Lee; J C Izpisua-Belmonte; I M Verma
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

Authors:  A A Beg; D Baltimore
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

8.  Identification and characterization of an IkappaB kinase.

Authors:  C H Régnier; H Y Song; X Gao; D V Goeddel; Z Cao; M Rothe
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

Review 9.  IL-6 and NF-IL6 in acute-phase response and viral infection.

Authors:  S Akira; T Kishimoto
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

10.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.

Authors:  M L Scott; T Fujita; H C Liou; G P Nolan; D Baltimore
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

View more
  191 in total

Review 1.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

3.  The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.

Authors:  A Devin; Y Lin; S Yamaoka; Z Li; M Karin
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 4.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 5.  Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Authors:  I M Verma
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

7.  Klf6/copeb is required for hepatic outgrowth in zebrafish and for hepatocyte specification in mouse ES cells.

Authors:  Xiao Zhao; Christopher Monson; Chuan Gao; Valerie Gouon-Evans; Nobuyuki Matsumoto; Kirsten C Sadler; Scott L Friedman
Journal:  Dev Biol       Date:  2010-04-27       Impact factor: 3.582

Review 8.  Signaling to NF-kappaB: regulation by ubiquitination.

Authors:  Ingrid E Wertz; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 9.  Role of IKKα in skin squamous cell carcinomas.

Authors:  Eunmi Park; Bigang Liu; Xiaojun Xia; Feng Zhu; Willette-Brown Jami; Yinling Hu
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

10.  Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.

Authors:  Soo-Ho Choi; Kyu-Jin Park; Byung-Yoon Ahn; Guhung Jung; Michael M C Lai; Soon B Hwang
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.